These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7593132)

  • 21. Effect of graded renal ablation on kidney and serum insulin-like growth factor-I (IGF-I) and IGF binding proteins in rats: relation to compensatory renal growth.
    Grønboek H; Nielsen B; Flyvbjerg A; Orskov H
    Metabolism; 1997 Jan; 46(1):29-35. PubMed ID: 9005965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI; Anker GB; Tally M; Hall K; Lønning PE
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet.
    Donovan SM; Chao JC; Zijlstra RT; Odle J
    J Pediatr Gastroenterol Nutr; 1997 Feb; 24(2):174-82. PubMed ID: 9106104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature.
    Rooman RP; De Beeck LO; Martin M; van Doorn J; Mohan S; Du Caju MV
    Eur J Endocrinol; 2005 Apr; 152(4):597-604. PubMed ID: 15817916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women.
    Helle SI; Anker GB; Meadows KA; Holly JM; Lønning PE
    Maturitas; 1998 Jan; 28(3):259-65. PubMed ID: 9571602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
    Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
    Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs.
    Vinter-Jensen L; Juhl CO; Frystyk J; Dajani EZ; Oksbjerg N; Flyvbjerg A
    J Endocrinol; 1996 Dec; 151(3):401-7. PubMed ID: 8994385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
    Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
    Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional regulation of IGF-II, but not IGF-I, is age dependent in sheep.
    Oldham JM; Martyn JA; Hua KM; MacDonald NA; Hodgkinson SC; Bass JJ
    J Endocrinol; 1999 Dec; 163(3):395-402. PubMed ID: 10588812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional modulation of canine insulin-like growth factors and their binding proteins.
    Maxwell A; Butterwick R; Yateman M; Batt RM; Cotterill A; Camacho-Hübner C
    J Endocrinol; 1998 Jul; 158(1):77-85. PubMed ID: 9713329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute and chronic food restriction on the insulin-like growth factor axis in the guinea pig.
    Sohlström A; Katsman A; Kind KL; Grant PA; Owens PC; Robinson JS; Owens JA
    J Endocrinol; 1998 Apr; 157(1):107-14. PubMed ID: 9614364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum insulin-like growth factor-I and breast cancer.
    Toniolo P; Bruning PF; Akhmedkhanov A; Bonfrer JM; Koenig KL; Lukanova A; Shore RE; Zeleniuch-Jacquotte A
    Int J Cancer; 2000 Dec; 88(5):828-32. PubMed ID: 11072255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.